Table 2.
Correlation of ROSE with pathology in malignant cases (n = 462).
| ROSE | Histopathology | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| SCC | AC | NSCLC | SCLC | Suspicious cancer | Other malignancy | Metastasis | Non malignant | Total | |
| SCC | 126 | 9 | 6 | 3 | 4 | 6 | 16 | 170 | |
| AC | 10 | 87 | 6 | 0 | 3 | 1 (FLAC) | 11 | 7 | 125 |
| NSCLC | 6 | 3 | 35 | 0 | 4 | 1 (SARC) | 49 | ||
| SCLC | 0 | 3 | 0 | 94 | 0 | 1 | 98 | ||
| Suspicious cancer | 5 | 6 | 2 | 2 (MEC/ACC) | 3 | 0 | 18 | ||
| Other malignancy | 2 (Lymphoma) | 2 | |||||||
| Metastasis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Non malignant | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total | 147 | 108 | 49 | 97 | 11 | 6 | 20 | 24 | 462 |